News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • PayPal trades below a prior $60.50 bid, leaving a deal overhang that pressures the stock despite solid cash generation.
  • Bank of Korea minutes show the board ready to raise rates further, signaling tighter monetary policy ahead.
  • U.S. futures rose after indications of resumed Iran talks and strong tech earnings, lifting risk assets and sentiment.
  • Rocket Lab faces near-term financing and dilution risk from an $8 billion Iridium deal and a $3.6 billion bridge loan.
  • AppLovin shows revenue and margin momentum driven by e-commerce monetization, supporting upside into the Q2 print.
  • Verbio beat upgraded guidance with €192 million EBITDA and reduced net debt, sending its shares higher in Europe.

Latest Articles

Zelenskiy Says Russia Ignoring Kyiv-Proposed Pause as Strikes Continue

Zelenskiy Says Russia Ignoring Kyiv-Proposed Pause as Strikes Continue

President Volodymyr Zelenskiy said Russia continued to violate a Kyiv-proposed ceasefire that would have begun on May 6, and signaled Ukraine would keep up long-range strikes if attacks persist. Moscow has not confirmed adherence to the Kyiv proposal and both sides reported substantial drone activity and attacks on energy and military-industrial ta…

Kremlin says security for Putin will be increased ahead of Victory Day events

Kremlin says security for Putin will be increased ahead of Victory Day events

The Kremlin announced heightened security measures for President Vladimir Putin ahead of May 9 Victory Day commemorations, citing what it described as a 'terrorist threat' from Ukraine. Kremlin spokesman Dmitry Peskov said additional protections are customary for major holidays but are being reinforced this year. Moscow has also scaled back the Red…

Entrada Therapeutics Reports First Quarter 2026 Financial Results

Entrada Therapeutics Reports First Quarter 2026 Financial Results

Entrada Therapeutics announced positive topline results from Cohort 1 of its ELEVATE-44-201 Phase 1/2 study for Duchenne muscular dystrophy (DMD), demonstrating favorable safety, tolerability, and early functional benefits. The company maintains a strong cash position with $255 million, providing runway into Q3 2027, and plans upcoming data release…

Gilat to Present at Upcoming Investor Conferences

Gilat to Present at Upcoming Investor Conferences

Gilat Satellite Networks Ltd. announced that their CFO, Gil Benyamini, will present and attend the upcoming 21st Annual Needham Technology, Media, & Consumer 1x1 Conference and the 27th Annual Oppenheimer Israel Conference. The company is a leading provider of satellite communications technology and solutions, serving commercial and defense sectors…

Xometry Reports Record First Quarter 2026 Results

Xometry Reports Record First Quarter 2026 Results

Xometry announced record Q1 2026 financial results with 36% revenue growth to $205 million driven by 40% marketplace revenue growth. The company improved Adjusted EBITDA to $10.5 million and expanded active buyers and accounts with significant spend. A strategic partnership with Siemens includes a $50 million equity purchase, reinforcing confidence…

Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates

Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates

Iovance Biotherapeutics announced robust first quarter 2026 financial results, with total product revenue rising approximately 45% year-over-year to $71 million. The company provided strong guidance for Q2 and full year 2026 revenues, driven primarily by growth in Amtagvi sales. Clinical progress includes a 40% confirmed objective response rate in …

Appian Announces First Quarter 2026 Financial Results

Appian Announces First Quarter 2026 Financial Results

Appian Corporation announced its financial results for Q1 2026, showing significant growth in cloud subscription revenue by 25% year-over-year, total revenue up 21%, and a turnaround to GAAP operating income from a loss in the previous year. The company also raised guidance for 2026, projecting continued double-digit growth in cloud subscriptions a…

Resolute Holdings Reports First Quarter 2026 Results

Resolute Holdings Reports First Quarter 2026 Results

Resolute Holdings Management, Inc. reported robust first quarter 2026 financial results, posting a net income per share of $7.19, a substantial improvement from a loss last year. Non-GAAP Fee-Related Earnings per share rose to $0.69, driven by new management agreements and organic fee growth. The company also repurchased $38 million in shares, high…

GPGI Reports First Quarter 2026 Results

GPGI Reports First Quarter 2026 Results

GPGI, Inc. announced its Q1 2026 results, showing a 3% increase in pro forma adjusted net sales to $421.2 million and record sales growth at CompoSecure driven by the Resolute Operating System (ROS). However, Husky Technologies faced unexpected headwinds from volatile oil and resin prices and tariff uncertainty, resulting in a 16% decline in pro fo…

Amazon Pharmacy to Stock Ozempic Pill at Kiosks, Adds Same-Day Delivery

Amazon Pharmacy to Stock Ozempic Pill at Kiosks, Adds Same-Day Delivery

Amazon said it will carry Novo Nordisk's Ozempic pill for type 2 diabetes at its pharmacy kiosks and provide same-day delivery in select areas, expanding its distribution of GLP-1 medications alongside existing offerings such as Wegovy. The company detailed pricing, kiosk availability, and delivery reach while reiterating prior investments to broad…

Polestar’s Q1 Loss Widens as Discounts and U.S. Tariffs Squeeze Margins

Polestar’s Q1 Loss Widens as Discounts and U.S. Tariffs Squeeze Margins

Electric vehicle maker Polestar reported a larger first-quarter net loss as pricing discounts in Europe and U.S. tariffs weighed on profitability despite a modest rise in deliveries. Revenue held roughly steady while cash reserves declined and expenses rose, prompting the company to accelerate business-model and manufacturing-efficiency changes wit…

Global chip rally lifts Asian markets as oil retreat eases pressure

Global chip rally lifts Asian markets as oil retreat eases pressure

A renewed surge in chip and tech-related stocks pushed Asian markets higher as Japan returned from Golden Week, led by large gains in SoftBank. The move adds to a strong year for Asian benchmarks and contrasts with more modest gains in U.S. indices. Falling oil prices on hopes of a U.S.-Iran deal helped ease bond yields, even as sporadic military a…

Citi cuts buy ratings on Nordic carriers as growth momentum cools

Citi cuts buy ratings on Nordic carriers as growth momentum cools

Citi Research has moved Telia, Tele2 and Telenor from buy to neutral and kept Elisa at neutral, citing slower underlying EBITDA momentum, the near-term loss of some wholesale revenue, and the annualisation of cost savings. Q1 results showed price-driven service revenue gains but firm warned that much of the profit uplift was driven by FY25 cost red…

Lifetime Brands, Inc. Reports First Quarter 2026 Financial Results

Lifetime Brands, Inc. Reports First Quarter 2026 Financial Results

Lifetime Brands, Inc. reported Q1 2026 financial results that beat consensus estimates with 2.4% net sales growth and improved EBITDA, driven by strong performance in Home Solutions and kitchen tools segments. The company implemented early pricing strategies and cost structure actions that are now yielding benefits. Lifetime Brands also commissione…

Weight Watchers Announces First Quarter 2026 Results

Weight Watchers Announces First Quarter 2026 Results

WW International, Inc. announced its Q1 2026 financial results with total subscribers at 2.7 million and clinical subscribers increasing 46% year-over-year. The company reported $168 million in revenue, with clinical subscription revenue up 32%. WW reaffirmed its full-year 2026 revenue and adjusted EBITDA guidance and announced a fully subscribed d…